Virginia Cardiovascular Specialists
Cardiology practice
Based in VA
🤖
AI Overview
With $0 in lobbying spend across 6 quarterly filings, Virginia Cardiovascular Specialists is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2021 to 2022.
$0
Total Spend
2
Years Active
1
Firms Hired
1
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $0 |
| 2022 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid
- •monitor appropriate use criteria for advanced medical imaging; monitor telehealth legislation; monitor PPP legislation; oppose site neutral legislation
- •oppose cuts to advanced medical imaging; support appropriateness criteria for diagnostic imaging;oppose site neutral cuts; monitor legislation affecting EHR and HIT;monitor PPP legislation; monitor te
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
National Community Pharmacists Association
$15.4M total spend
Healthcare Distribution Alliance (Formerly - Hdma)
$13.2M total spend
American Academy of Otolaryngology-head and Neck Surgery
$8.0M total spend
Infectious Diseases Society of America
$5.1M total spend
National Hospice and Palliative Care Organization
$5.0M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.